DYN Dyne Therapeutics

Watchlist

13.910
-0.140-1.00%

Close Feb 14 16:00 ET

14.290
+0.380+2.73%

Post 20:01 ET

1.42BMarket Cap-3.89P/E (TTM)

About Dyne Therapeutics Company

Dyne Therapeutics Inc is a biotechnology company focused on providing therapeutics for patients with genetically driven diseases. The company overcomes the limitations of muscle tissue delivery and modern oligonucleotide therapeutics for muscle diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. The company's product candidates are DYNE-101 and DYNE-251, both are in the ongoing phase 1/2 clinical trial.

Company Profile

SymbolDYN

Company NameDyne Therapeutics

Listing DateSep 17, 2020

Issue Price19.00

Founded2017

CEOMr. John G. Cox

MarketNASDAQ

Employees141

Fiscal Year Ends12-31

Address830 Winter Street

CityWaltham

ProvinceMassachusetts

CountryUnited States of America

Zip Code02451

Phone1-781-786-8230

Websitehttp://www.dyne-tx.com

Company Executives

Name
Position
Salary

John G. Cox
Director, President and Chief Executive Officer
--

Wildon Farwell, M.D.,M.P.H.
Chief Medical Officer
--

Dr. Oxana Beskrovnaya, PhD
Chief Scientific Officer
--

Richard William Scalzo
Senior Vice President, Head of Finance and Administration, Principal Financial and Accounting Officer
--

Jason P. Rhodes
Chairman of the Board
283.17K

Edward M. Hurwitz, J.D.
Independent Director
250.17K

Dirk Kersten
Independent Director
262.67K

David Charles Lubner, C.P.A.,M.S.
Independent Director
264.17K

Dr. Catherine Stehman-Breen, M.D.
Independent Director
253.92K

Dr. Carlo Incerti
Independent Director
250.17K

DYN Dyne Therapeutics

About Dyne Therapeutics Company

Company Profile

Company Executives

Trending Stocks